The importance of understanding cognitive trajectories: the case of 22q11.2 deletion syndrome

被引:22
|
作者
Swillen, Ann [1 ,2 ,3 ]
机构
[1] Univ Hosp Gasthuisberg, Dept Human Genet, B-3000 Louvain, Belgium
[2] Univ Hosp Gasthuisberg, Dept Rehabil Sci, B-3000 Louvain, Belgium
[3] Univ Hosp Gasthuisberg, Ctr Human Genet, Herestr 49, B-3000 Louvain, Belgium
关键词
22q11; 2 deletion syndrome; divergent cognitive trajectories; variability in cognitive abilities; CARDIO-FACIAL-SYNDROME; DEVELOPMENTAL TRAJECTORIES; VELOCARDIOFACIAL SYNDROME; PSYCHIATRIC-DISORDERS; SYNDROME VCFS; CHILDREN; ADULTS; SCHIZOPHRENIA; PROFILE; MICRODELETION;
D O I
10.1097/YCO.0000000000000231
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Purpose of reviewThe 22q11.2 deletion syndrome (velo-cardio-facial syndrome or DiGeorge syndrome) is the most common known contiguous gene deletion syndrome, and is associated with neurodevelopmental problems and diverse neuropsychiatric disorders across the life span. In this review, we discuss the wide variability in intelligence, the developmental phenotypic transitions regarding cognitive development (intelligence) from preschool to adolescence, and the importance of understanding these cognitive trajectories in 22q11.2 deletion syndrome for care/management and research.Recent findingsLongitudinal data on the cognitive development of children and adolescents with 22q11.2 deletion syndrome reveal divergent cognitive trajectories. A decline in verbal intelligence quotient precedes the onset of psychosis in 22q11.2 deletion syndrome.SummaryUnderstanding these cognitive trajectories is important since it can guide clinicians to develop adequate support, tailored remediation, and psychiatric care and individualized follow-up.
引用
收藏
页码:133 / 137
页数:5
相关论文
共 50 条
  • [41] HYPERPROLINEMIA AND PSYCHIATRY IN 22Q11.2 DELETION SYNDROME
    van Asbeck, E.
    Morava-Kozicz, E.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (02) : 454 - 454
  • [42] Immunological aspects of 22q11.2 deletion syndrome
    A. R. Gennery
    Cellular and Molecular Life Sciences, 2012, 69 : 17 - 27
  • [43] Complement Activation in 22q11.2 Deletion Syndrome
    Dina Grinde
    Torstein Øverland
    Kari Lima
    Camilla Schjalm
    Tom Eirik Mollnes
    Tore G. Abrahamsen
    Journal of Clinical Immunology, 2020, 40 : 515 - 523
  • [44] Neuroradiographic findings in 22q11.2 deletion syndrome
    Bohm, Lauren A.
    Zhou, Tom C.
    Mingo, Tyler J.
    Dugan, Sarah L.
    Patterson, Richard J.
    Sidman, James D.
    Roby, Brianne B.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2017, 173 (08) : 2158 - 2165
  • [45] Heterotopia in Individuals with 22q11.2 Deletion Syndrome
    Neuhaus, E.
    Hattingen, E.
    Breuer, S.
    Steidl, E.
    Polomac, N.
    Rosenow, F.
    Rueber, T.
    Herrmann, E.
    Ecker, C.
    Kushan, L.
    Lin, A.
    Vajdi, A.
    Bearden, C. E.
    Jurcoane, A.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2021, 42 (11) : 2070 - 2076
  • [46] Immunologic defects in 22q11.2 deletion syndrome
    McLean-Tooke, Andrew
    Barge, Dawn
    Spickett, Gavin P.
    Gennery, Andrew R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (02) : 362 - 367
  • [47] Neurological manifestation of 22q11.2 deletion syndrome
    Bayat, Michael
    Bayat, Allan
    NEUROLOGICAL SCIENCES, 2022, 43 (03) : 1695 - 1700
  • [48] Obesity in adults with 22q11.2 deletion syndrome
    Voll, Sarah L.
    Boot, Erik
    Butcher, Nancy J.
    Cooper, Samantha
    Heung, Tracy
    Chow, Eva W. C.
    Silversides, Candice K.
    Bassett, Anne S.
    GENETICS IN MEDICINE, 2017, 19 (02) : 204 - 208
  • [49] The development of cognitive control in children with chromosome 22q11.2 deletion syndrome
    Shapiro, Heather M.
    Tassone, Flora
    Choudhary, Nimrah S.
    Simon, Tony J.
    FRONTIERS IN PSYCHOLOGY, 2014, 5
  • [50] IMMUNE CTYOPENIAS IN 22Q11.2 DELETION SYNDROME
    Zobi, Mohamed
    Awajneh, Mohamad
    Talati, Ravi
    Lesmana, Harry
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S149 - S150